Market Research Reports and Industry Reports

World Anti-Inflammatory Therapeutics Market - Opportunities and Forecasts, 2014 - 2020

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

Inflammation is triggered by the defense system of the body in response to harmful stimuli, damaged cells, irritants and microorganisms. Inflammation is the mechanism of innate immunity, which seeks to eliminate the cause of injury, clear dead and necrotic cells and heal injured tissues. Sometimes, the body defense system inappropriately triggers inflammation against its own cells, resulting in incurable inflammatory autoimmune diseases such as arthritis, asthma and chronic obstructive pulmonary disease (COPD). According to World Health Organization (WHO), approximately 235 million people suffer from asthma in the world. Symptomatic relief during the inflammation provides relief to the patients suffering from inflammatory autoimmune diseases. Although there are multiple anti-inflammatory drugs approved in the market, there is an indispensable need for better and novel anti-inflammatory therapeutics with lesser side effects and better efficacy.

The global anti-inflammatory therapeutics market is expected to grow at a CAGR of 5.9% over the forecast period, owing to the emergence of anti-inflammatory biologics that are more targeted, effective and with lesser side effects as compared to conventional drugs. In addition, they are also difficult to imitate due to their complex molecular structure and origin. The global anti-inflammatory market has been driven by factors such as increasing autoimmune and respiratory conditions, new drugs in pipeline and increasing adoption of anti-inflammatory drugs. Moreover, increasing awareness of anti-inflammatory therapeutics and attractive government initiatives in the Asia-Pacific and LAMEA region are expected to drive the market during the analysis period. Factors, such as side effects of anti-inflammatory drugs and patent expiry issues of blockbuster drugs (such as Remicade), are known to impede the market growth.

The global anti-inflammatory therapeutics market is segmented on the basis of indication, drug class and geography. The indications considered in this report include arthritis, respiratory diseases, multiple sclerosis, psoriasis, inflammatory bowel disease and other inflammatory diseases. Among indications, arthritis holds tremendous potential for growth accounting for 38.2% of the global anti-inflammatory therapeutics market. Anti-inflammatory biologics are the most preferred drugs for treatment of arthritis. On the basis of drug class, the market is segmented into anti-inflammatory biologics, non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. Anti-inflammatory biologics holds the largest share among drug classes accounting for 54.8% share of the global anti-inflammatory therapeutics market, and is expected grow rapidly during the forecast period.

Geographically, the market is segmented into four regions namely North America, Europe, Asia-Pacific and LAMEA. Among regions, North America holds the largest share accounting for 45.7% share of the global anti-inflammatory therapeutics market; however, the Asia-Pacific region is expected to exhibit the fastest growth during the forecast period. Major market players have adopted innovative strategies such novel drug development and product launch (novel and indication expansion) to increase their market presence. In 2014, AstraZeneca had five anti-inflammatory drugs in the final stages of drug development. These drugs are lesinurad, sifalimumab, anifrolumab, mavrilimumab and brodalumab. The companies have filed new patents to overcome the issues of patent expiries of their existing drugs, and to gain a prominent market share. The key companies profiled in this report include Pfizer, Inc., Abbvie, Inc., Johnson & Johnson, GlaxoSmithKline, Merck & CO., Inc., Novartis, F. Hoffman, La Roche AG, Eli Lily and Company, AstraZeneca PLC, and Amgen.

KEY MARKET BENEFITS:

The report provides a quantitative analysis of the current market and estimations during 2014 - 2020 that assist in identifying the prevailing market opportunities to capitalize.
Exhaustive analysis of the global anti-inflammatory therapeutics market by product type helps in understanding the types of therapeutics that are currently being used along with the categories that would gain prominence in the future.
Competitive intelligence (of leading manufacturers and distributors of anti-inflammatory therapeutics) helps in understanding the competitive scenario across the geographies.
Comprehensive analysis of factors that drive and restrict the growth of the global anti-inflammatory therapeutics market is provided.
SWOT analysis enables to study the internal environment of the leading companies for strategy formulation.
The Country level analysis of anti-inflammatory therapeutics market conditions has been provided in this report.

KEY MARKET SEGMENTS:

The Global Anti-inflammatory Therapeutics Market is segmented below:

Global Anti-inflammatory Therapeutics Market By Indication
Arthritis
Respiratory diseases
Multiple sclerosis
Psoriasis
Inflammatory bowel disease
Other inflammatory diseases
Global Anti-inflammatory Therapeutics Market Drug Class
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory drugs (NSAIDs)
Corticosteroids
Global Anti-inflammatory Therapeutics Market By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
Germany
France
Others
Asia-Pacific
China
Japan
India
Others
LAMEA
Latina America
Middle East and Africa

Chapter: 1 INTRODUCTION
 
 1.1 Report Description
 1.2 Key Market Benefits
 1.3 Key Market Segments
 1.4 Research Methodology
 
 1.4.1 Secondary research
 1.4.2 Primary research
 1.4.3 Analyst tools and models
 
 Chapter: 2 EXECUTIVE SUMMARY
 
 2.1 CXO Perspective
 2.2 Market Beyond What to Expect by 2025 ($million)
 
 2.2.1 Moderate growth scenario
 2.2.2 Rapid growth scenario
 2.2.3 Diminishing growth scenario
 
 Chapter: 3 MARKET OVERVIEW
 
 3.1 Market Definition and Scope
 3.2 Key Findings
 
 3.2.1 Top impacting factors
 3.2.2 Top investment pockets
 3.2.3 Top winning strategies
 
 3.3 Government Regulation
 3.4 Reimbursement Scenario
 3.5 Porters Five Force Analysis
 
 3.5.1 Complex and highly differentiated nature of raw materials increases bargaining power of suppliers
 3.5.2 Fewer manufacturers of anti-inflammatory drugs limits the bargaining power of buyers
 3.5.3 High capital investment and patent provision lowers the threats from new entrants
 3.5.4 Difficulty to imitate the original biologics lowers the threat of substitutes
 3.5.5 Industry rivalry is low to moderate due to presence of few competitors
 
 3.6 Value Chain Analysis
 
 3.7 Market Share Analysis, 2014
 
 3.8 Market Dynamics
 
 3.8.1 Drivers
 
 3.8.1.1 Rising incidences of autoimmnue and respiratory conditions:
 3.8.1.2 New Drugs in Pipeline
 3.8.1.3 Increasing adoption rate of anti-inflammatory drugs
 
 3.8.2 Restraints
 
 3.8.2.1 Side effects of anti-inflammtory drugs
 3.8.2.2 Patenet expiries
 
 3.8.3 Opportunities
 
 3.8.3.1 Developing biosimilars for the existing drugs
 3.8.3.2 Tapping the emerging markets in developing regions
 
 Chapter: 4 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET BY INDICATION
 
 4.1 Market size and forecast by Indication
 
 4.2.1 Market size and forecast by region
 4.2.2 Rheumatoid Arthritis
 4.2.3 Osteoarthritis
 4.2.4 Ankylosing Spondylitis
 4.2.5 Psoriatic Arthritis
 4.2.6 Gout
 
 4.3 Respiratory Diseases
 
 4.3.1 Market size and forecast by region
 4.3.2 Asthma
 4.3.3 Chronic obstructive pulmonary disease (COPD)
 
 4.4 Multiple Sclerosis
 
 4.4.1 Market size and forecast by region
 
 4.5 Psoriasis
 
 4.5.1 Market size and forecast by region
 
 4.6 Inflammatory Bowel Disease (IBD)
 
 4.6.1 Market size and forecast by region
 4.6.2 Crohns Disease
 4.6.3 Ulcerative Colitis
 
 4.7 Other Inflammatory Diseases
 
 4.7.1 Market size and forecast by region
 
 Chapter: 5 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS
 
 5.1 Anti-inflammatory Biologics
 
 5.1.1 Key market trend
 5.1.2 Market growth factors and opportunities
 5.1.3 Market size and forecast by region
 
 5.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
 
 5.2.1 Key market trend
 5.2.2 Market growth factors and opportunities
 5.2.3 Market size and forecast by region
 
 5.3 Corticosteroids
 
 5.3.1 Key market trends
 5.3.2 Market growth factors and opportunities
 5.3.3 Market size and forecast by region
 
 5.4 Other Anti-Inflammatory Drugs
 
 Chapter: 6 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET BY GEOGRAPHY
 
 6.1 North America
 
 6.1.1 Key market trends
 6.1.2 Key growth factors and opportunities
 6.1.3 Market size and forecast
 6.1.4 United States
 6.1.5 Canada
 6.1.6 Mexico
 
 6.2 Europe
 
 6.2.1 Key market trends
 6.2.2 Key growth factors and opportunities
 6.2.3 Market size and forecast
 6.2.4 United Kingdom
 6.2.5 Germany
 6.2.6 France
 6.2.7 Rest of Europe
 
 6.3 Asia Pacific
 
 6.3.1 Key growth factors and opportunities
 6.3.2 Market size and forecast
 6.3.3 Japan
 6.3.4 China
 6.3.5 India
 6.3.6 Rest of Asia Pacific
 
 6.4 LAMEA
 
 6.4.1 Key market trends
 6.4.2 Key growth factors and opportunities
 6.4.3 Market size and forecast
 6.4.4 Latin America
 6.4.5 Middle East and Africa
 
 Chapter: 7 COMPANY PROFILES
 
 7.1 Pfizer Inc.
 
 7.1.1 Company overview
 7.1.2 Company snapshot
 7.1.3 Business performance
 7.1.4 Strategic moves and developments
 7.1.5 SWOT analysis of Pfizer, Inc.
 
 7.2 AbbVie Inc.
 
 7.2.1 Company overview
 7.2.2 Company snapshot
 7.2.3 Business performance
 7.2.4 Strategic Moves and Developments
 7.2.5 SWOT analysis of AbbVie Inc.
 
 7.3 Johnson & Johnson
 
 7.3.1 Company overview
 7.3.2 Company snapshot
 7.3.3 Business performance
 7.3.4 Strategic moves and developments
 7.3.5 SWOT analysis & strategic conclusions
 
 7.4 GlaxoSmithKline plc
 
 7.4.1 Company overview
 7.4.2 Company snapshot
 7.4.3 Business performance
 7.4.4 Strategic moves and developments
 7.4.5 SWOT analysis & strategic conclusions
 
 7.5 Merck & Co., Inc.
 
 7.5.1 Company overview
 7.5.2 Company snapshot
 7.5.3 Business performance
 7.5.4 Strategic moves and developments
 7.5.5 SWOT analysis and strategic conclusions
 
 7.6 Novartis AG
 
 7.6.1 Company overview
 7.6.2 Company snapshot
 7.6.3 Business Performance
 7.6.4 Strategic moves and developments
 7.6.5 SWOT analysis and strategic conclusions
 
 7.7 F. Hoffmann-La Roche AG
 
 7.7.1 Company overview
 7.7.2 Company snapshot
 7.7.3 Business performance
 7.7.4 Strategic moves and developments
 7.7.5 SWOT analysis and strategic conclusions
 
 7.8 Eli Lily and Company
 
 7.8.1 Company overview
 7.8.2 Company snapshot
 7.8.3 Business performance
 7.8.4 Strategic moves and developments
 7.8.5 SWOT analysis and strategic conclusions
 
 7.9 AstraZeneca PLC.
 
 7.9.1 Company overview
 7.9.2 Company snapshot
 7.9.3 Business performance
 7.9.4 Strategic moves and developments
 7.9.5 SWOT analysis and strategic conclusions
 
 7.10 Amgen Inc.
 
 7.10.1 Company overview
 7.10.2 Company snapshot
 7.10.3 Business performance
 7.10.4 Strategic moves and developments
 7.10.5 SWOT analysis and strategic conclusions


List Of Tables

TABLE 1 GLOBAL ANTI-INFLAMMTORY THERAPEUTICS MARKET MODERATE GROWTH SCENARIO, REVENUE BY GEOGRAPHY, 2020-2025 ($ MILLION)
 TABLE 2 GLOBAL ANTI-INFLAMMTORY THERAPEUTICS MARKET RAPID GROWTH SCENARIO REVENUE BY GEOGRAPHY, 2020-2025 ($ MILLION)
 TABLE 3 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET DIMINISHING GROWTH SCENARIO REVENUE BY GEOGRAPHY, 2020-2025 ($ MILLION)
 TABLE 4 PATENT EXPIRY OF MAJOR BRANDS
 TABLE 5 PROJECTED INCIDENCE OF ARTHRITIS IN U.S
 TABLE 6 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET, BY INDICATION, 2014-2020, ($MILLION)
 TABLE 7 GLOBAL ARTHRITIS ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLION
 TABLE 8 GLOBAL RESPIRATORY DISEASES ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLION
 TABLE 9 GLOBAL MULTIPLE SCLEROSIS ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLION
 TABLE 10 GLOBAL PSORIASIS ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLION
 TABLE 11 GLOBAL INFLAMMTORY BOWEL DISEASE ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLION
 TABLE 12 GLOBAL OTHER INFLAMMTORY DISEASES ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLION
 TABLE 13 GLOBAL ANTI INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS, 2014-2020, $MILLION
 TABLE 14 GLOBAL TOP SELLING BIOLOGIC ANTI-INFLAMMATORY BRANDS, 2014 ($MILLION)
 TABLE 15 GLOBAL ANTI-INFLAMMATORY BIOLOGICS THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
 TABLE 16 GLOBAL NSAIDS THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
 TABLE 17 GLOBAL TOP SELLING CORTICOSTEROIDS ANTI-INFLAMMATORY BRANDS, 2014 ($MILLION)
 TABLE 18 GLOBAL CORTICOSTEROIDS ANTI-INFLAMMATORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
 TABLE 19 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
 TABLE 20 NORTH AMERICA ANTI-INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS, 2014-2020 ($MILLION)
 TABLE 21 NORTH AMERICA ANTI-INFLAMMATORY THERAPEUTICS MARKET BY COUNTRY, 2014-2020 ($MILLION)
 TABLE 22 EUROPE ANTI-INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS, 2014-2020 ($MILLION)
 TABLE 23 EUROPE ANTI-INFLAMMATORY THERAPEUTICS MARKET BY COUNTRY, 2014-2020 ($MILLION)
 TABLE 24 ASIA PACIFIC ANTI-INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS, 2014-2020 ($MILLION)
 TABLE 25 ASIA PACIFIC ANTI-INFLAMMATORY THERAPEUTICS MARKET BY COUNTRY, 2014-2020 ($MILLION)
 TABLE 26 LAMEA ANTI-INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS, 2014-2020 ($MILLION)
 TABLE 27 LATIN AMERICA ANTI-INFLAMMATORY THERAPEUTICS MARKET BY COUNTRY, 2014-2020 ($MILLION)
 TABLE 28 PFIZER INC SNAPSHOT
 TABLE 29 ABBVIE INC. SNAPSHOT
 TABLE 30 JOHNSON & JOHNSON SNAPSHOT
 TABLE 31 GLAXOSMITHKLINE SNAPSHOT
 TABLE 32 MERCK & CO SNAPSHOT
 TABLE 33 NOVARTIS AG SNAPSHOT
 TABLE 34 F. HOFFMANN-LA ROCHE AG SNAPSHOT
 TABLE 35 ELI LILLY SNAPSHOT
 TABLE 36 ASTRAZENECA SNAPSHOT
 TABLE 37 AMGEN INC SNAPSHOT


List Of Figures

FIG. 1 TOP IMPACTING FACTORS, MODERATE GROWTH SCENARIO (2020-2025)
 FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2020-2025)
 FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2020-2025)
 FIG. 4 TYPES OF ANTI-INFALMMATORY THERAPEUTICS:
 FIG. 5 TOP FACTORS IMPACTING ON GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET (2014-2020)
 FIG. 6 TOP INVESTMENT POCKETS OF ANTI-INFLAMMATORY THERAPEUTICS MARKET (2014)
 FIG. 7 TOP WINNING STRATEGIES IN ANTI-INFLAMMATORY THERAPEUTICSMARKET
 FIG. 8 PHARMACEUTICALS REGULATORY PATHWAY (U.S.)
 FIG. 9 PORTERS FIVE FORCES ANALYSIS
 FIG. 10 VALUE CHAIN OF GLOBAL ANTI-INFLAMMTORY THERAPEUTICS MARKET
 FIG. 11 MARKET SHARE ANALYSIS, 2014
 FIG. 12 FINANCIAL REVENUES BY BUSINESS SEGMENTS (2014)
 FIG. 13 FINANCIAL REVENUES BY GEOGRAPHY (2014)
 FIG. 14 FINANCIAL REVENUES BY YEAR ($MILLION)
 FIG. 15 SWOT ANALYSIS & STRATEGIC CONCLUSIONS
 FIG. 16 ABBVIE, INC. FINANCIAL REVENUES BY YEAR ($MILLION)
 FIG. 17 FINANCIAL REVENUES OF HUMIRA ($MILLION)
 FIG. 18 SWOT ANALYSIS & STRATEGIC CONCLUSIONS
 FIG. 19 PHARMACEUTICALS SALES BY GEOGRAPHY (2014)
 FIG. 20 SWOT ANALYSIS & STRATEGIC CONCLUSIONS
 FIG. 21 GLAXOSMITHKLINES FINANCIAL REVENUES BY GEOGRAPHY (2014)
 FIG. 22 FINANCIAL REVENUES BY THERAPY AREA
 FIG. 23 SWOT ANALYSIS & STRATEGIC CONCLUSIONS
 FIG. 24 FINANCIAL REVENUES BY YEAR ($MILLION)
 FIG. 25 FINANCIAL REVENUES BY GEOGRAPHY (2014)
 FIG. 26 SWOT ANALYSIS & STRATEGIC CONCLUSIONS
 FIG. 27 FINANCIAL REVENUES BY GEOGRAPHY (2014)
 FIG. 28 FINANCIAL REVENUES BY SEGMENT (2014)
 FIG. 29 SWOT ANALYSIS & STRATEGIC CONCLUSIONS
 FIG. 30 FIANANCIAL REVENUES BY THERAPEUTIC SEGMENTS (2014)
 FIG. 31 FINANCIAL REVENUES OF PHARMACEUTICALS BY REGION
 FIG. 32 SWOT ANALYSIS AND STRATEGIC CONCLUSIONS
 FIG. 33 FINANCIAL REVENUES BY BUSINESS SEGMENTS (2014)
 FIG. 34 SWOT ANALYSIS AND STRATEGIC CONCLUSIONS
 FIG. 35 FINANCIAL REVENUES BY GEOGRAPHY (2014)
 FIG. 36 FINANCIAL REVENUES BY YEAR ($MILLION)
 FIG. 37 SWOT ANALYSIS AND STRATEGIC CONCLUSIONS
 FIG. 38 FINANCIAL REVENUES BY PRODUCT (2014)
 FIG. 39 FINANCIAL REVENUES BY YEAR ($MILLION)
 FIG. 40 SWOT ANALYSIS AND STRATEGIC CONCLUSIONS


NJEDA – Camden World Trade Center – New Jersey - Construction Project Profile

Synopsis NJEDA Camden World Trade Center New Jersey contains information on the scope of the project including project overview and location. The profile also details project ownership and funding,

USD 75View Report

NOBC – World Trade Center Building Redevelopment – Louisiana - Construction Project Profile

Synopsis NOBC World Trade Center Building Redevelopment Louisiana contains information on the scope of the project including project overview and location. The profile also details project ownership and funding,

USD 75View Report

PJL – World Trade Center III Development – Indonesia - Construction Project Profile

Synopsis PJL World Trade Center III Development Indonesia contains information on the scope of the project including project overview and location. The profile also details project ownership and funding,

USD 75View Report

Global Anti-Inflammatory Therapeutics Market Professional Survey Report 2016

Notes:Production, means the output of Anti-Inflammatory TherapeuticsRevenue, means the sales value of Anti-Inflammatory TherapeuticsThis report studies Anti-Inflammatory Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia

USD 3500View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF $ 4515    $ 4515
  • Site Licence $ 7350    $ 7350
  • Global Licence $ 10680    $ 10680
  • Hard copy $ 5325    $ 5325
  • CD $ 5325    $ 5325
$ 4515

Reports Details

Published Date : Sep 2015
No. of Pages :136
Country :Global
Category :Telecommunications
Publisher :Allied Market Research
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment